Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure
Status:
Unknown status
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the therapeutic efficacy of allogenic bone marrow
stem cells (BMSCs) transplantation in patients with liver failure caused by hepatitis B
infection. The evaluation of the efficacy includes the level of serum alanine
aminotransferase (ALT), aspartate aminotransferase(AST), total bilirubin (TB),prothrombin
time (PT), albumin (ALB), prealbumin(PA), liver histological improvement before and 1 week to
1 year after transplantation. Child-Pugh scores, MELD scores and clinical symptoms were also
observed simultaneously.